Document Detail

Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.
MedLine Citation:
PMID:  16764655     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Eosinophils are important effector cells in severe allergic conjunctivitis such as vernal keratoconjunctivitis. Infiltration of eosinophils into the conjunctiva is mediated by type I and type IV allergic reactions. Cyclosporin A (CsA) eye drops are administered therapeutically for severe allergic conjunctivitis, but the mechanism by which CsA acts, that is, by inhibiting type I, type IV or both types of allergic reactions, is not known. We investigated whether CsA eye drops inhibit type I, type IV or both types of allergic reactions in the conjunctiva. METHODS: Experimental immune-mediated blepharoconjunctivitis (EC) was induced in BALB/c mice by either active immunization or passive immunization by transfer of ragweed (RW)-primed splenocytes and RW-specific IgE, followed by RW challenge to the conjunctiva. These mice were treated in eye drops with vehicle, 0.1% CsA, 0.5% CsA or 0.1% betamethasone five times (1 and 2 h before RW challenge and 1, 2 and 3 h after RW challenge). Twenty-four hours after the challenge, the conjunctivas were harvested for histological analysis to evaluate eosinophilic infiltration. To evaluate effects of CsA eye drops on systemic immune responses, sera and spleens were collected from actively immunized mice at the time of sacrifice to examine serum IgE levels and cellular immune responses, respectively. RESULTS: CsA eye drops significantly inhibited eosinophilic infiltration into the conjunctiva in actively immunized EC-developing mice compared with vehicle-treated mice. The CsA-induced inhibition was similar to inhibition induced by 0.1% betamethasone. Serum IgE levels and splenocyte responses in CsA-treated mice were equivalent to those in vehicle-treated mice. Betamethasone treatment inhibited eosinophilic infiltration into the conjunctiva induced by both splenocyte transfer and IgE transfer, while CsA treatment inhibited infiltration induced by splenocyte transfer. CONCLUSIONS: CsA eye drops inhibited eosinophilic infiltration into the conjunctiva without affecting systemic immune responses. CsA predominantly inhibits eosinophilic infiltration by interfering with the type IV allergic reaction in the conjunctiva.
Atsuki Fukushima; Tomoko Yamaguchi; Waka Ishida; Kazuyo Fukata; Fu-Tong Liu; Hisayuki Ueno
Related Documents :
14720275 - Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments i...
12066845 - Intracellular signal transduction in eosinophils and its clinical significance.
7690315 - Fk506 and rapamycin modulate the functional activities of human peripheral blood eosino...
18282775 - Phosphodiesterase 4 inhibitors delay human eosinophil and neutrophil apoptosis in the a...
25141135 - Gba2-encoded β-glucosidase activity is involved in the inflammatory response to pseudom...
4056035 - Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in t...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical & experimental ophthalmology     Volume:  34     ISSN:  1442-6404     ISO Abbreviation:  Clin. Experiment. Ophthalmol.     Publication Date:    2006 May-Jun
Date Detail:
Created Date:  2006-06-12     Completed Date:  2006-08-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  100896531     Medline TA:  Clin Experiment Ophthalmol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  347-53     Citation Subset:  IM    
Department of Ophthalmology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku-city, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Betamethasone / administration & dosage
Blepharitis / immunology,  prevention & control
Cell Movement / drug effects*
Conjunctivitis, Allergic / immunology,  prevention & control*
Cyclosporine / administration & dosage*
Cytokines / analysis
Eosinophils / physiology*
Hypersensitivity, Delayed / immunology,  prevention & control*
Immunization, Passive
Immunoenzyme Techniques
Immunoglobulin E / blood
Immunosuppressive Agents / administration & dosage*
Lymphocyte Activation / drug effects
Mice, Inbred C57BL
Ophthalmic Solutions / administration & dosage
T-Lymphocytes / immunology
Reg. No./Substance:
0/Cytokines; 0/Immunosuppressive Agents; 0/Ophthalmic Solutions; 37341-29-0/Immunoglobulin E; 378-44-9/Betamethasone; 59865-13-3/Cyclosporine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Delayed ocular complications of mustard gas poisoning and the relationship with respiratory and cuta...
Next Document:  Magnetic resonance imaging assessment of fibrovascular ingrowth into porous polyethylene orbital imp...